Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Enrolling by invitation · NCT07353294 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC | Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bladder transitional cell carcinoma, neoplasm | Enrolling by invitation | Phase 1 | 2026-04-22 | NCT07353294 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 22 |